A study published in the Proceedings of the National Academy of Sciences has uncovered new clues to why some therapeutic proteins are so difficult to manufacture. The work—led by Nathan Lewis, PhD, ...
Researchers from New York plan to screen a library of 10 10 molecules to train an artificial intelligence (AI) model. The model, developed by software startup DeepSeq.AI, aims to help manufacturers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results